2013 Press Releases

    Print Page  Close Window
Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
12/31/13Wexford Science & Technology Acquires Chesterfield Building in Durham, North Carolina
BALTIMORE, Md., Dec. 31, 2013 /PRNewswire/ -- Wexford Science & Technology, a BioMed Realty (NYSE: BMR) company, today announced the acquisition of the Chesterfield Building site in downtown Durham, North Carolina for total consideration of $7.5 million.  The seven-story Chesterfield Building was once part of the Liggett & Myers Tobacco Company complex.  It is one of the last remaining historic warehouses yet to be redeveloped in downtown Durham. The Chesterfield Building is in close ... 
Printer Friendly Version
12/18/13BioMed Realty Trust Appoints Dr. William R. Brody, President Of The Salk Institute, To Its Board Of Directors
SAN DIEGO, Dec. 18, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the appointment of Dr. William R. Brody, President of the Salk Institute for Biological Studies, to its board of directors, increasing the board to nine members. "It is with great pleasure that we welcome Dr. Brody to our board," said Alan D. Gold, Chairman and Chief Executive Officer of BioMed Realty. "He is recognized internationally for his accomplishments in biomedical engineering, including ov... 
Printer Friendly Version
12/16/13BioMed Realty Trust Declares Fourth Quarter 2013 Common Stock Dividend
Increases dividend by 6.4% SAN DIEGO, Dec. 16, 2013 /PRNewswire/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a fourth quarter 2013 dividend of $0.25 per share of common stock, representing a 6.4% increase over the company's third quarter 2013 dividend of $0.235 per share. The dividend is equivalent to an annualized dividend of $1.00 per common share. The common stock dividend is payable on January 15, 2014 to stockholders of record at t... 
Printer Friendly Version
11/05/13BioMed Realty Trust Reports Third Quarter 2013 Financial Results
Wexford Operating Properties Achieve Early Stabilization; Same Property Cash NOI Increases 5.7%, Year-over-Year SAN DIEGO, Nov. 5, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), the leading provider of real estate to the life science industry, today announced financial results for the third quarter ended September 30, 2013. Third Quarter 2013 Highlights Executed 37 leasing transactions during the quarter represen... 
Printer Friendly Version
10/28/13Regeneron And BioMed Realty Break Ground On A New 300,000 Square Foot R&D Build-to-Suit Facility In Westchester County, New York
SAN DIEGO, Oct. 28, 2013 /PRNewswire/ -- Joined by New York Senator Charles E. Schumer and state, county and local government leaders, senior management from Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and BioMed Realty Trust, Inc. (NYSE: BMR) broke ground today on a new 300,000 square foot build-to-suit research facility for Regeneron at BioMed Realty's The Landmark at Eastview campus in Westchester County, New York. Employees from both companies gathered for the groundbreaking ceremony at t... 
Printer Friendly Version
10/23/13BioMed Realty Trust to Report 2013 Third Quarter Results
SAN DIEGO, Oct. 23, 2013 (GLOBE NEWSWIRE) -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced it will report results for its third quarter ended September 30, 2013 after the market closes on Tuesday, November 5, 2013. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Wednesday, November 6, 2013 to discuss t... 
Printer Friendly Version
09/30/13BioMed Realty Increases Capacity Under Credit Facility To $1.25 Billion
SAN DIEGO, Sept. 30, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that the company has amended and restated its senior unsecured credit facility, increasing the revolving capacity under the credit facility to $900 million and adding a $350 million term loan.  The maturity date of the amended credit facility was extended to March 24, 2018, but can be extended for six months to September 24, 2018 at the company's option.  In addition, the terms of the amended and rest... 
Printer Friendly Version
09/26/13New 62,600 Square Foot Lease At 650 East Kendall Street Signed By Ipsen And BioMed Realty
SAN DIEGO, Sept. 26, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced the signing of a long-term new lease for approximately 62,600 square feet of laboratory and office space in Cambridge, Massachusetts at 650 East Kendall Street, a six-story, state-of-the-art multi-tenant research facility in the heart of the Kendall Square biotechnology super-cluster, which BioMed Realty owns through a joint venture with Prudential Real Estate Inv... 
Printer Friendly Version
09/16/13BioMed Realty Trust Declares Third Quarter 2013 Common Stock Dividend
SAN DIEGO, Sept. 16, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a third quarter 2013 dividend of $0.235 per share of common stock. The dividend is equivalent to an annualized dividend of $0.94 per common share. The common stock dividend is payable on October 15, 2013 to stockholders of record at the close of business on September 30, 2013.  About BioMed Realty Trust BioMed Realty delivers optimal real estate solu... 
Printer Friendly Version
08/06/13BioMed Realty Trust Reports Second Quarter 2013 Financial Results
Second Quarter Leasing Volume of 898,000 Square Feet - Largest in Company History SAN DIEGO, Aug. 6, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust (REIT) that delivers optimal real estate solutions for the life science industry, today announced financial results for the second quarter ended June 30, 2013. Second Quarter 2013 Highlights Executed 20 leasing transactions during the quarter representing approximately 898,000 squar... 
Printer Friendly Version
07/29/13BioMed Realty Trust to Report 2013 Second Quarter Results
SAN DIEGO, July 29, 2013 (GLOBE NEWSWIRE) -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced it will report results for its second quarter ended June 30, 2013 after the market closes on Tuesday, August 6, 2013. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Wednesday, August 7, 2013 to discuss the compa... 
Printer Friendly Version
06/20/13BioMed Realty Acquires 320 Charles In Cambridge, MA
99,500 Square Feet Adjacent to Company's Rogers Street Assets SAN DIEGO, June 20, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that it has completed the acquisition of 320 Charles Street in Cambridge, Massachusetts in a transaction valued at $52 million.  The property comprises approximately 99,500 square feet of laboratory and office space currently leased to The Whitehead Institute for BioMedical Research.  In connection with the acquisition, BioMed Realty issu... 
Printer Friendly Version
06/17/13BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend
SAN DIEGO, June 17, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a second quarter 2013 dividend of $0.235 per share of common stock. The dividend is equivalent to an annualized dividend of $0.94 per common share. The common stock dividend is payable on July 15, 2013 to stockholders of record at the close of business on June 28, 2013.  About BioMed Realty Trust BioMed Realty delivers optimal real estate solutions fo... 
Printer Friendly Version
06/04/13BioMed Realty Trust To Present At REITWeek 2013
SAN DIEGO, June 4, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that members of its executive management will present at REITWeek® 2013: NAREIT's Investor Forum in Chicago on Wednesday, June 5, 2013 at approximately 4:30 p.m. Central Daylight Time. A live webcast of the presentation will be available to all investors by accessing the company's website at www.biomedrealty.com. The complete webcast will be archived for 30 days. About BioMed Realty Trust BioM... 
Printer Friendly Version
06/03/13BioMed Realty And Wexford Science & Technology Complete Merger
BioMed Realty Expands Footprint in University/Research Markets with 1.6 Million Square Feet of High-Quality Assets and 935,000 Square Feet of Development Projects SAN DIEGO and BALTIMORE, June 3, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) and Wexford Science & Technology, LLC announced today that they have completed their previously announced merger. The Wexford Science & Technology platform will operate as a wholly-owned subsidiary of BioMed Realty, developing institu... 
Printer Friendly Version
05/01/13BioMed Realty Trust Reports First Quarter 2013 Financial Results
First Quarter Leasing Volume of 583,700 Square Feet SAN DIEGO, May 1, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust (REIT) that delivers optimal real estate solutions for the life science industry, today announced financial results for the first quarter ended March 31, 2013. First Quarter 2013 Highlights Executed 29 leasing transactions during the quarter representing approximately 583,700 square feet, contributing to an operating portfolio... 
Printer Friendly Version
04/23/13BioMed Realty Trust To Report 2013 First Quarter Results
SAN DIEGO, April 23, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its first quarter ended March 31, 2013 after the market closes on Wednesday, May 1, 2013. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 9:00 a.m. Pacific Time on Thursday, May 2, 2013 to discuss the company's fin... 
Printer Friendly Version
04/18/13BioMed Realty Introduces Its 2012 Online Annual Report
SAN DIEGO, April 18, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that its 2012 Online Annual Report and other proxy materials are now available at http://www.biomedrealty.com/12AR. BioMed Realty is posting its annual report in an online format following the SEC-approved electronic reporting guidelines for the fifth consecutive year. Entitled "Discover Here," the 2012 Online Annual Report illustrates the company's commitment to serving the unique needs of the li... 
Printer Friendly Version
04/08/13BioMed Realty Announces 31,500 Square Foot Lease Expansion With Risk Management Solutions At The Pacific Research Center
Over 82,000 Square Feet of New Leasing Signed at PRC in 2013 SAN DIEGO, April 8, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that Risk Management Solutions, Inc. ("RMS"), a leader in risk modeling for businesses, has leased an additional 31,500 square feet at its Pacific Research Center in Newark, California. As a result of this lease expansion, RMS' occupancy at Pacific Research Center North will increase to approximately 134,000 square feet, all of which exten... 
Printer Friendly Version
04/04/13BioMed Realty To Develop 297,000 Square Feet In New York Fully Leased To Regeneron Pharmaceuticals
SAN DIEGO, April 4, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that it will commence construction on two new buildings comprising approximately 297,000 square feet and a parking structure at The Landmark at Eastview in Tarrytown, New York, expanding the campus to approximately 1.4 million square feet.   The to-be-built laboratory and office space is 100% pre-leased for a 15-year lease term to Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Regeneron, a fully integ... 
Printer Friendly Version
04/02/13BioMed Realty Trust Announces Exercise Of Option To Purchase Additional Shares Of Common Stock
SAN DIEGO, April 2, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the full exercise of the underwriters' option to purchase additional shares of common stock in connection with BioMed Realty's previously announced follow-on offering that priced on March 27, 2013. In total, the company sold 17,250,000 shares of common stock in the offering, raising gross offering proceeds of approximately $369.2 million. Morgan Stanley & Co. LLC, Raymond James & Associates,... 
Printer Friendly Version
03/27/13BioMed Realty Trust Prices Public Offering Of 15,000,000 Shares Of Common Stock
SAN DIEGO, March 27, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the pricing of its public offering of 15,000,000 shares of its common stock at $21.40 per share.  The offering is expected to close on or about April 2, 2013.  The gross proceeds from the offering will be approximately $321.0 million.  BioMed Realty expects to use the net proceeds of the offering to fund a portion of the purchase price for the recently announced, pending acquisition of Wexford Science... 
Printer Friendly Version
03/26/13BioMed Realty Trust Announces Public Offering Of 15,000,000 Shares Of Common Stock
SAN DIEGO, March 26, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it has commenced a public offering of 15,000,000 shares of its common stock pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission.  BioMed Realty expects to use the net proceeds of the offering to fund a portion of the purchase price for the recently announced, pending acquisition of Wexford Science & Technology, LLC, to repay a portion of the outs... 
Printer Friendly Version
03/26/13Wexford Science & Technology To Merge With BioMed Realty Trust
BioMed Realty Adds 1.6 Million Square Foot Portfolio & Expands University / Research Institution Segment to 18% of Annualized Base Rents SAN DIEGO and BALTIMORE, March 26, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that it has entered into a definitive agreement to merge with Wexford Science & Technology, LLC, a subsidiary of Wexford Equities, LLC, furthering BioMed Realty's position as the leading provider of real estate to the life science industry.  ... 
Printer Friendly Version
03/20/13BioMed Realty To Lease 204,900 Square Feet To Life Technologies At The Science Center at Oyster Point In South San Francisco
Concurrently Agrees to Terminate Lease with Elan Corporation and Acquire Foster City Campus from Life Technologies SAN DIEGO, March 20, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of two new leases for 15 years with Life Technologies Corporation (NASDAQ: LIFE) at its Science Center at Oyster Point property in the heart of the South San Francisco, California life science submarket. Life Technologies, a global biotechnology company, will fully occupy 2... 
Printer Friendly Version
03/18/13BioMed Realty Trust Declares First Quarter 2013 Common Stock Dividend
SAN DIEGO, March 18, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a first quarter 2013 dividend of $0.235 per share of common stock, The dividend is equivalent to an annualized dividend of $0.94 per common share. The common stock dividend is payable on April 15, 2013 to stockholders of record at the close of business on March 28, 2013.  About BioMed Realty Trust BioMed Realty delivers optimal real estate solution... 
Printer Friendly Version
02/19/13BioMed Realty Trust Announces Exercise Of Option To Purchase Additional Shares Of Common Stock
SAN DIEGO, Feb. 19, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the full exercise of the underwriters' option to purchase additional shares of common stock in connection with BioMed Realty's previously announced follow-on offering that priced on February 13, 2013. In total, the company sold 14,605,000 shares of common stock in the offering, raising gross offering proceeds of approximately $299.4 million. Morgan Stanley & Co. LLC, Raymond James &... 
Printer Friendly Version
02/13/13BioMed Realty Trust Prices Public Offering Of 12,700,000 Shares Of Common Stock
SAN DIEGO, Feb. 13, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the pricing of its public offering of 12,700,000 shares of its common stock at $20.50 per share.  The offering is expected to close on or about February 19, 2013.  The gross proceeds from the offering will be approximately $260.4 million.  BioMed Realty expects to use the net proceeds of the offering to fund a recently announced property acquisition, to fund a portion of the redemption of all 7,920,0... 
Printer Friendly Version
02/12/13BioMed Realty Trust Provides Notice of Redemption of 7.375% Series A Cumulative Redeemable Preferred Stock
SAN DIEGO, Feb. 12, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) (the "Company"), a real estate investment trust (REIT) that delivers optimal real estate solutions for the life science industry, today announced that it delivered a notice of the Company's intention to redeem all 7,920,000 outstanding shares of its 7.375% Series A Cumulative Redeemable Preferred Stock (the "Series A preferred stock") (NYSE: BMRPrA; CUSIP No.: 09063H206) from the registered holders of the Series A p... 
Printer Friendly Version
02/12/13BioMed Realty Trust Announces Public Offering Of 11,500,000 Shares Of Common Stock
SAN DIEGO, Calif., Feb. 12, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it has commenced a public offering of 11,500,000 shares of its common stock pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission.  BioMed Realty expects to use the net proceeds of the offering to fund a recently announced property acquisition, to fund a portion of the redemption of all 7,920,000 outstanding shares of its 7.375% Ser... 
Printer Friendly Version
02/05/13BioMed Realty Trust Reports Fourth Quarter And Full-Year 2012 Financial Results
Fourth Quarter Leasing Volume of 624,900 Square Feet; Fourth Quarter FFO and AFFO per Share Up 20.0% and 17.9% Over 2011, Respectively SAN DIEGO, Feb. 5, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust (REIT) that delivers optimal real estate solutions for the life science industry, today announced financial results for the fourth quarter and full-year ended December 31, 2012. Fourth Quarter 2012 Highlights Executed 30 leasing transactions du... 
Printer Friendly Version
01/28/13BioMed Realty Trust To Report 2012 Fourth Quarter And Year End Results
SAN DIEGO, Jan. 28, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its fourth quarter and year ended December 31, 2012 after the market closes on Tuesday, February 5, 2013. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 11:00 a.m. Pacific Time on Wednesday, February 6, 2013 to d... 
Printer Friendly Version
01/17/13BioMed Realty Trust Announces Tax Treatment Of 2012 Distributions
SAN DIEGO, Jan. 17, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2012 distributions as follows: Security Description: Common Stock CUSIP: 09063H107 Ticker Symbol: BMR Record Date Payable Date Total Distribution Per Share Allocable to 2012 Taxable Ordinary Dividend   Return of Capital Long-Term Capital Gain Unrecaptured Section 1250 Gain 12/30/201... 
Printer Friendly Version
01/04/13BioMed Realty Trust Appoints Former Amylin President And Chief Executive Officer To Its Board Of Directors
SAN DIEGO, Jan. 4, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the appointment of Daniel M. Bradbury to its board of directors, increasing the board to eight members. "We are pleased to welcome Dan to our board," said Alan D. Gold, Chairman and Chief Executive Officer of BioMed Realty. "Dan brings his extensive knowledge of the life science industry, as well as proven experience as a successful and dynamic leader, which we believe will contribute significantl... 
Printer Friendly Version